The KRT10 gene plays a crucial role in the health and integrity of the skin. Mutations in this gene are associated with a rare genetic disorder known as epidermolytic hyperkeratosis (EHK), characterized by blistering and thickening of the skin. This condition, also known as bullous congenital ichthyosiform erythroderma, can significantly impact the quality of life of affected individuals.
To diagnose this condition accurately, a genetic test targeting the KRT10 gene can be conducted. DNA Labs UAE offers this specialized genetic testing service, allowing for the precise identification of mutations in the KRT10 gene. The test is crucial for confirming the diagnosis of EHK, enabling targeted management and counseling for affected individuals and their families.
The cost of the KRT10 gene test at DNA Labs UAE is 4400 AED. This investment covers the collection of a DNA sample, usually through a blood draw or cheek swab, and its subsequent analysis in the laboratory. The process involves sophisticated genetic sequencing technologies to identify any mutations in the KRT10 gene that may be responsible for the condition. Results from this test can provide essential information for the clinical management of EHK, including prognosis, potential complications, and the risk of passing the condition to future generations.
The KRT9 Gene Epidermolytic Palmoplantar Keratoderma Genetic Test is a specialized diagnostic procedure offered at DNA Labs UAE, designed to identify mutations in the KRT9 gene, which are responsible for the development of Epidermolytic Palmoplantar Keratoderma (EPPK). EPPK is a rare genetic skin disorder characterized by thickening of the skin on the palms of the hands and soles of the feet, often leading to significant discomfort and potential complications. This test is crucial for individuals with a family history of the condition or those exhibiting symptoms, as it provides definitive genetic evidence of EPPK, enabling informed decisions regarding management and treatment options. The cost of the test is 4400 AED, reflecting the specialized nature of the analysis and the comprehensive insights it offers into the genetic underpinnings of this condition. DNA Labs UAE, renowned for its state-of-the-art facilities and expert staff, ensures accurate and reliable results, making it a trusted choice for genetic testing services.
The COMP Gene Epiphyseal Dysplasia Multiple Type 1 Genetic Test is a specialized diagnostic assessment available at DNA Labs UAE. This test is designed to identify mutations in the COMP gene, which are known to cause Multiple Epiphyseal Dysplasia Type 1 (MED1), a rare genetic disorder affecting the development of bones and cartilage. This condition typically manifests in early childhood, leading to joint pain, malformations, and potential growth abnormalities.
By analyzing a patient's DNA, the test aims to confirm a diagnosis of MED1, enabling healthcare providers to tailor treatment plans and offer genetic counseling based on the specific mutation present. The cost of the test is 4400 AED, reflecting the comprehensive nature of the analysis and the sophisticated technology employed to ensure accurate results. Conducted at DNA Labs UAE, a facility renowned for its advanced genetic testing services, this test represents a crucial step for affected individuals and their families in managing and understanding the implications of Multiple Epiphyseal Dysplasia Type 1.
The FKBP14 Gene Ehlers-Danlos Syndrome with Progressive Kyphoscoliosis, Myopathy, and Hearing Loss Genetic Test is a comprehensive diagnostic tool available at DNA Labs UAE, designed to identify mutations in the FKBP14 gene. These mutations are associated with a rare form of Ehlers-Danlos Syndrome (EDS), characterized by progressive kyphoscoliosis, muscle weakness (myopathy), and hearing loss, among other symptoms. The test plays a crucial role in the early detection and management of this condition, enabling healthcare providers to develop personalized treatment plans for affected individuals. Priced at 4400 AED, this genetic test is a significant investment in understanding and managing the complexities of this specific type of EDS, offering hope and direction for patients and their families navigating the challenges associated with the syndrome.
The CHST14 Gene Ehlers-Danlos Syndrome Musculocontractural Type 1 Genetic Test is a specialized diagnostic examination aimed at identifying mutations in the CHST14 gene, which are linked to Ehlers-Danlos Syndrome Musculocontractural Type 1 (EDSMC1). This condition is a rare type of Ehlers-Danlos Syndrome (EDS) characterized by multiple congenital contractures, skin hyperextensibility, and craniofacial abnormalities, among other symptoms. The test plays a crucial role in the early detection and management of this genetic disorder, enabling healthcare providers to tailor treatment plans and provide genetic counseling to affected individuals and their families.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed for specific mutations in the CHST14 gene. The presence of these mutations confirms the diagnosis of EDSMC1, providing valuable information for the patient's care plan.
The cost of the CHST14 Gene Ehlers-Danlos Syndrome Musculocontractural Type 1 Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the comprehensive nature of the test, encompassing the intricate processes of sample collection, genetic analysis, and the provision of a detailed report by the laboratory's genetic experts. Patients interested in undergoing this test are advised to consult with their healthcare provider to understand its benefits, implications, and the process involved.
The DSE Gene Ehlers-Danlos Syndrome Musculocontractural Type 2 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the DSE gene. These mutations are associated with Ehlers-Danlos Syndrome Musculocontractural Type 2 (EDS MC Type 2), a rare genetic disorder characterized by multiple systemic involvements. This includes skin hyperextensibility, abnormal wound healing, muscle contractures, and skeletal abnormalities. The test is crucial for individuals showing symptoms of the disorder or those with a family history, as it provides definitive genetic evidence of the condition. By conducting a thorough analysis of the DSE gene, healthcare professionals can make accurate diagnoses, enabling them to tailor management and treatment plans effectively for affected individuals. The test is priced at 4400 AED and is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring high-quality, reliable results.
The B4GALT7 gene plays a critical role in the synthesis of glycosaminoglycans, essential components for the structural integrity and function of connective tissues. Mutations in the B4GALT7 gene are associated with Ehlers-Danlos Syndrome Progeroid Type 1 (EDSP1), a rare genetic disorder characterized by features of premature aging (progeroid features), distinct facial appearance, and various connective tissue abnormalities including skin hyperelasticity and joint hypermobility.
To diagnose this condition, genetic testing is available at DNA Labs UAE. The test specifically looks for mutations in the B4GALT7 gene that are indicative of EDSP1. This testing is crucial for accurate diagnosis, enabling appropriate management and genetic counseling for affected individuals and their families. The cost of the B4GALT7 Gene Ehlers-Danlos Syndrome Progeroid Type 1 Genetic Test at DNA Labs UAE is 4400 AED. This test is a valuable tool for healthcare professionals and patients alike, offering insights into the genetic basis of the condition and aiding in the development of a tailored care plan.
The B3GALT6 gene is associated with Ehlers-Danlos syndrome, progeroid type 2, a rare genetic disorder characterized by features including skin hyperelasticity, fragile connective tissues, and skeletal abnormalities. This condition is part of the Ehlers-Danlos syndrome (EDS) spectrum, a group of disorders affecting the connective tissues that provide support to skin, bones, blood vessels, and other organs and tissues.
The genetic test for the B3GALT6 gene aims to identify mutations that cause Ehlers-Danlos syndrome, progeroid type 2. This test is crucial for confirming the diagnosis, understanding the risk of passing the condition to future generations, and guiding management and treatment decisions.
In the UAE, DNA Labs offers this specialized genetic test. The cost of the test is 4400 AED. DNA Labs UAE is equipped with state-of-the-art technology and staffed by professionals with expertise in genetic testing and analysis. By choosing DNA Labs UAE for the B3GALT6 gene test, individuals can expect accurate and reliable results, which are essential for managing Ehlers-Danlos syndrome, progeroid type 2, effectively.
The GATA2 Gene Emberger Syndrome Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the GATA2 gene, which are associated with Emberger Syndrome. This condition is a rare genetic disorder characterized by primary lymphedema (swelling due to fluid retention), a predisposition to myelodysplastic syndrome (a type of blood disorder), acute myeloid leukemia, and other hematologic malignancies. Individuals with Emberger Syndrome may also exhibit features such as sensorineural hearing loss and distinct facial anomalies.
The test is conducted through a comprehensive analysis of the GATA2 gene, looking for specific mutations that confirm the diagnosis of Emberger Syndrome. This genetic testing is crucial for affected individuals and their families for several reasons. Firstly, it provides a definitive diagnosis, which is essential for the appropriate management and treatment of the condition. Secondly, it helps in understanding the risk of developing related hematologic diseases. Lastly, it offers the possibility of genetic counseling for family members, informing them about the risk of inheriting or passing on the condition.
DNA Labs UAE offers this genetic test at a cost of 4400 AED. The test is conducted with a high level of accuracy and confidentiality, ensuring that patients receive reliable results and comprehensive support throughout the testing process. For individuals showing symptoms of Emberger Syndrome or those with a family history of the condition, this test represents a critical step in confirming the diagnosis and initiating appropriate medical interventions.
The COL7A1 Gene Epidermolysis Bullosa Dystrophica Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the COL7A1 gene. These mutations are responsible for causing Dystrophic Epidermolysis Bullosa (DEB), a rare genetic skin disorder characterized by extreme fragility of the skin and mucous membranes, leading to blistering and scarring. The test, priced at 4400 AED, involves analyzing the patient's DNA to detect any abnormalities in the COL7A1 gene, which plays a crucial role in the production of type VII collagen, a protein essential for skin strength and integrity. This genetic testing is vital for early diagnosis, guiding treatment options, and offering genetic counseling for affected families. By pinpointing the specific genetic alterations causing DEB, the test aids in understanding the severity of the condition, potential complications, and the risk of passing the disorder to future generations.
